- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02396173
Does the Knowledge of a "Non-return to Work" Predictive Score Influence Vocational Rehabilitation? (WORRK)
Does the Knowledge of a "Non-return to Work" Predictive Score Influence Vocational Rehabilitation After Orthopaedic Trauma?
Study Overview
Detailed Description
Methods:
Vocational inpatients after orthopaedic trauma (n=280), aged between 18-60 years. Three different vocational pathways can be selected: Simple (for patients with low "non-return to work" risk, 5 weeks stay), Coaching (intermediate risk, 5 weeks), Evaluation (high risk, 3 weeks). Design: randomized-controlled trial. In the intervention group, the probability not to return to work estimated with the WORRK model will be offered to the clinician team before the allocation decisions. In the control group, the probability will also be estimated but not known by the clinician team. The primary outcome is the proportion of patients allocated to the Evaluation Pathway. Secondary outcomes: the patients' satisfaction is not worse in the intervention group; the decisions makers' satisfaction with the information available for the decision process is better in the intervention group; the proportion of patients changing the treatment pathway during the vocational stay is not higher in the intervention group; and the calibration of the WORRK model remains satisfactory; the non-return to work rate is not higher in the intervention group than in the control group (follow-up at 3, 12, and 24 months);
Relevance and impact:
The investigators expect that the WORRK model will improve the efficiency of vocational rehabilitation after orthopedic trauma. This will due to better allocation to the vocational pathways according to the patients' risk profile. If this is the case, an increase of the shorter vocational program is expected without jeopardizing the chance of returning to work and the patient satisfaction with quality of care. The ability of the WORRK model to detect patients with similar risk profiles could also strengthen the interest for this decision-supportive tool in clinical practice and trials.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Valais
-
Sion, Valais, Switzerland, 1951
- Clinique romande de réadaptation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients hospitalized for a vocational rehabilitation programme after an orthopaedic trauma
Exclusion Criteria:
- Severe traumatic brain injury at time of accident (Glasgow coma Scale ≤8)
- Spinal Cord Injury
- Not capable of judgment
- Under legal custody
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Risk Score for non-return to work
The WORRK model is a predictive tool (19 items) of the non-return to work risk useful for all kinds of orthopaedic trauma and for patients needing vocational rehabilitation.
It is constructed with variables independent of the patient's education and language fluency.
It is a short patient's bedside tool and takes less than 20 minutes.
|
The WORRK tool will be filled in for all patients, even the patients in the control group.
However, the probability score will only be accessible for the medical doctors in the intervention group, along with guidelines for interpretation ("1.
With a probability score over 50% (not to return to work), patient's allocation to the "Evaluation Pathway" should be considered" "2.
With a probability score over 70% (not to return to work), the "Evaluation Pathway" is probably the most suitable choice").
|
|
No Intervention: Control group
In this group the medical staff will not be informed about the risk score (WORRK).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Allocation to the evaluation pathway (proportion of patients allocated to the Evaluation Pathway)
Time Frame: 10 months
|
The primary outcome in the WORRK study is the proportion of patients allocated to the Evaluation Pathway.
|
10 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Return to work rate
Time Frame: 24 months
|
The non-return to work rate will be assessed by questionnaire at 3, 12 and 24 months after discharge.
|
24 months
|
|
the patients' satisfaction is not worse in the intervention group
Time Frame: 10 months
|
At discharge patients will fill a questionnaire to assess their satisfaction regarding the treatments received.
|
10 months
|
|
the decisions makers' satisfaction with the information available for the decision process is better in the intervention group
Time Frame: 10 months
|
Medical staff will assess efficiency of the intervention through a questionnaire
|
10 months
|
|
the proportion of patients changing the treatment pathway during the vocational stay is not higher in the intervention group
Time Frame: 10 months
|
To assess if patients change their clinical pathway during hospitalization.
Is there any differences between the intervention and control groups.
|
10 months
|
|
the calibration of the WORRK model remains satisfactory
Time Frame: 24 months
|
We will perform a new validation of the WORRK model on the population recruited from this study.
The performance of the WORRK prediction tool will be assessed with measures for calibration and discrimination.
For calibration we will plot the expected against the observed proportion of non-return to work per predicted risk group.
Furthermore, we will use the Hosmer-Lemeshow test to define statistical significance of the calibration.
For discrimination, we will plot the ROC-curve and calculate Areas under the ROC-curve (AUC).
We consider the performance of the WORRL acceptable if there is good calibration (i.e.
intercept not statistically different from 0 and slope of 1) and if the AUC is larger than 0.7.
|
24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: François Luthi, MD, Clinique romande de réadaptation
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CliniqueRR-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain
-
Flowonix MedicalApproved for marketingBack Pain | Leg Pain | Trunk Pain | Intractable Pain | Arm Pain
-
Universitat Jaume ICompletedPain, Acute | Pain, Chronic | OncologySpain
-
University Hospital Schleswig-HolsteinZealand University Hospital; European Regional Development Fund; Design School...CompletedPain, Acute | Pain, Chronic | Pain Measurement | Pain, CancerGermany
-
Boston Scientific CorporationRecruitingLow Back Pain | Chronic Pain | Chronic Low-back Pain | Leg Pain | Intractable Pain | Chronic Leg PainUnited States
-
University of Campinas, BrazilCompletedPREGNANCY | LUMBAR BACK PAIN | PELVIC PAIN
-
noiVita SrlsUniversity of Eastern PiedmontCompletedCervical Pain | Pain Management | Lumbar Pain | Muscular | Chronic Pain (Back / Neck)Italy
-
Qi's ClinicNot yet recruitingNon-Cancer Pain,Musculoskeletal Pain,Chronic Pain,Acute Pain
-
Chinese University of Hong KongNot yet recruitingPain, Acute | Chronic Post Operative Pain | Pain, ChronicHong Kong
-
University of SaskatchewanRoyal University Hospital FoundationCompletedPain | Pain, Acute | Pain, Chronic | Pain, IntractableCanada
-
Kyowa Kirin Co., Ltd.Completed
Clinical Trials on Risk Score for non-return to work
-
Université du Québec a MontréalCentre hospitalier de l'Université de Montréal (CHUM); Centre intégré de santé... and other collaboratorsCompletedCommon Mental DisorderCanada
-
Norwegian University of Science and TechnologyCompletedComplex Symptom DisordersNorway
-
Fujian Medical University Union HospitalRecruitingType B Aortic Dissection | Return to WorkChina
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Health Holland; TrimbosRecruitingMental Health | Return to WorkNetherlands
-
University Hospital, AngersNot yet recruitingLymphoma | Leukemia | Multiple MyelomaFrance
-
Karolinska InstitutetRegion StockholmCompletedAnxiety Disorders | Major Depression | Primary Insomnia | Stress DisordersSweden
-
New York State Psychiatric InstituteCompletedPersistent Depressive DisorderUnited States
-
Karolinska InstitutetRegion StockholmCompletedAnxiety Disorders | Major Depression | Primary Insomnia | Stress DisordersSweden
-
University Hospital, Strasbourg, FranceRecruitingHealth Related Quality of Life | Veno-arterial Extra-Corporeal Membrane OxygenationFrance
-
St. Joseph's Hospital and Medical Center, PhoenixChandler Regional Medical Center; Mercy Gilbert Medical CenterRecruitingCoronary Artery Disease | Genetic Predisposition to DiseaseUnited States